CN113952439A - Pill medicine for treating persistent cough and preparation method thereof - Google Patents
Pill medicine for treating persistent cough and preparation method thereof Download PDFInfo
- Publication number
- CN113952439A CN113952439A CN202111220593.9A CN202111220593A CN113952439A CN 113952439 A CN113952439 A CN 113952439A CN 202111220593 A CN202111220593 A CN 202111220593A CN 113952439 A CN113952439 A CN 113952439A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- cough
- pill
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The application discloses a pill medicine for treating persistent cough and a preparation method thereof, and compared with the prior art, the pill medicine comprises the following components in parts by weight: 0.6-1.5 parts of bulbus fritillariae cirrhosae, 0.3-1.8 parts of radix trichosanthis, 0.5-1.6 parts of flos farfarae, 0.8-1.2 parts of agilawood, 0.8-3 parts of myrobalan, 1-2.6 parts of mint leaf, 0.8-1.2 parts of radix asparagi, 0.3-1.8 parts of radix ophiopogonis, 0.6-1.8 parts of aster, 0.2-1.5 parts of radix scrophulariae, 0.4-2 parts of platycodon grandiflorum, 0.8-1.8 parts of meadowrue, 0.2-1.6 parts of five liao flavor, 0.4-1 part of dark plum pulp, 2-8 parts of dried persimmon, 0.8-2.6 parts of pear, 0.5-2.5 parts of radish, 1.5-3.6 parts of maltose, 0.1-0.8 parts of mirabilitum powder and 0.8-2 parts of ginger. The pill medicine for treating the persistent cough adopts the traditional Chinese medicine raw materials, has better safety, has the effects of relieving cough, reducing phlegm, eliminating sore throat, and moistening throat and trachea according to the efficacy of the traditional Chinese medicines of the raw materials, and enhances the treatment effect of patients with chronic cough.
Description
Technical Field
The application relates to the field of cough relieving medicines, in particular to a pill medicine for treating persistent cough and a preparation method thereof.
Background
Cough is a common respiratory symptom and can be caused by various diseases, such as bronchitis, upper respiratory infection, laryngitis, pneumonia and the like, usually manifested as the closing of self glottis, contraction of respiratory muscles and further opening of the glottis, usually accompanied with hoarseness, and meanwhile, the cough also has a certain protection effect and can help to remove respiratory foreign matters and secretions of people.
The western medicine can effectively dilate trachea and improve airway spasm for the treatment of chronic cough, but the patients still have a tendency of repeated attack, the treatment effect is not obvious, and the life quality of the patients is influenced.
Therefore, how to enhance the treatment effect of patients with chronic cough and improve the quality of life of patients with chronic cough has become a problem to be solved by those skilled in the art.
Disclosure of Invention
In order to solve the technical problems, the application provides a pill medicine for treating the cough, which can enhance the treatment effect of patients with chronic cough.
The technical scheme provided by the application is as follows:
the application provides a pill medicine for treating cough, which comprises the following components in parts by weight: 0.6-1.5 parts of bulbus fritillariae cirrhosae, 0.3-1.8 parts of radix trichosanthis, 0.5-1.6 parts of flos farfarae, 0.8-1.2 parts of agilawood, 0.8-3 parts of myrobalan, 1-2.6 parts of mint leaf, 0.8-1.2 parts of radix asparagi, 0.3-1.8 parts of radix ophiopogonis, 0.6-1.8 parts of aster, 0.2-1.5 parts of radix scrophulariae, 0.4-2 parts of platycodon grandiflorum, 0.8-1.8 parts of meadowrue, 0.2-1.6 parts of five liao flavor, 0.4-1 part of dark plum pulp, 2-8 parts of dried persimmon, 0.8-2.6 parts of pear, 0.5-2.5 parts of radish, 1.5-3.6 parts of maltose, 0.1-0.8 parts of mirabilitum powder and 0.8-2 parts of ginger.
Further, in a preferred mode of the invention, the composition comprises the following components in parts by weight: 0.8-1.2 parts of bulbus fritillariae cirrhosae, 0.5-1.4 parts of radix trichosanthis, 0.6-1.2 parts of flos farfarae, 0.8-1.1 parts of agilawood, 1.1-2.8 parts of myrobalan, 1.4-2.3 parts of mint leaf, 0.8-1.1 parts of radix asparagi, 0.6-1.5 parts of radix ophiopogonis, 0.8-1.4 parts of aster, 0.4-1.2 parts of radix scrophulariae, 0.6-1.8 parts of platycodon grandiflorum, 0.8-1.4 parts of meadowrue, 0.3-1.1 parts of Liaowuwei, 0.5-0.9 parts of dark plum pulp, 2-6 parts of dried persimmon, 1-2.2 parts of pear, 0.8-2.5 parts of radish, 1.6-3.2 parts of maltose, 0.1-0.5 parts of glauber salt and 0.8-1.5 parts of ginger.
Further, in a preferred mode of the invention, the composition comprises the following components in parts by weight: 0.8-1.1 part of bulbus fritillariae cirrhosae, 0.8-1.2 parts of radix trichosanthis, 0.8-1.1 part of flos farfarae, 0.9-1.1 part of agilawood, 1.5-2.4 parts of myrobalan, 1.6-2.2 parts of mint leaf, 0.9-1.1 part of radix asparagi, 0.8-1.2 parts of radix ophiopogonis, 0.9-1.3 parts of aster, 0.8-1.2 parts of radix scrophulariae, 0.8-1.3 parts of platycodon grandiflorum, 0.9-1.2 parts of meadowrue, 0.5-1 part of Liaowuwei, 0.6-0.9 part of dark plum pulp, 3-6 parts of dried persimmon, 1-2.2 parts of pear, 0.8-2.5 parts of radish, 1.8-2.8 parts of maltose, 0.1-0.4 part of mirabilitum and 0.8-1.5 part of ginger.
Further, in a preferred mode of the present invention, the pear is a pitted snow pear.
The application also provides a preparation method for preparing the pill medicine for treating the cough, which comprises the following steps:
s1, preparing medicinal powder: drying Bulbus Fritillariae Cirrhosae, Trichosanthis radix, flos Farfarae, lignum Aquilariae Resinatum, fructus Chebulae and folium Menthae, pulverizing, and sieving with 50 mesh sieve to obtain first medicinal powder;
s2, preparing pear juice: adding water, decocting the denucleated snow pears, and removing residues to obtain pear juice;
s3, preparing an ointment: respectively juicing ginger and radish, removing residues to obtain a mixed solution, drying and crushing cochinchnese asparagus root, dwarf lilyturf tuber, aster, radix scrophulariae, platycodon grandiflorum, meadowrue root, five flavors of Chinese Liaoning, dark plum pulp and mirabilitum dehydratum, sieving with a sieve of 100 meshes and 150 meshes to obtain a second medicinal powder, adding the second medicinal powder and maltose into the mixed solution, mixing, and heating to obtain a paste to obtain an ointment;
s4, preparing pills: mixing the ointment with the first medicinal powder, standing for 15-30 minutes, and making into pill.
Further, in a preferred mode of the present invention, the weight component of the pear juice in the step S2 is 8-15 parts.
In a preferred embodiment of the present invention, the weight fraction of the mixed solution in step S4 is 8 to 16 parts.
Further, in a preferred embodiment of the present invention, the weight component of the ginger juice in the step S4 is 0.1 part.
Compared with the prior art, the technical scheme provided by the invention is that the pill medicine for treating the persistent cough comprises the following components in parts by weight: 0.6 to 1.5 parts of bulbus fritillariae cirrhosae, 0.3 to 1.8 parts of radix trichosanthis, 0.5 to 1.6 parts of flos farfarae, 0.8 to 1.2 parts of agilawood, 0.8 to 3 parts of myrobalan, 1 to 2.6 parts of mint leaf, 0.8 to 1.2 parts of radix asparagi, 0.3 to 1.8 parts of radix ophiopogonis, 0.6 to 1.8 parts of aster, 0.2 to 1.5 parts of radix scrophulariae, 0.4 to 2 parts of platycodon grandiflorum, 0.8 to 1.8 parts of meadowrue, 0.2 to 1.6 parts of five liao flavor, 0.4 to 1 part of dark plum pulp, 2 to 8 parts of dried persimmon, 0.8 to 2.6 parts of pear, 0.5 to 2.5 parts of radish, 1.5 to 3.6 parts of maltose, 0.1 to 0.8 parts of mirabilitum powder and 0.8 to 2 parts of ginger, therefore, the traditional Chinese medicine raw materials are adopted, the safety is better, the effects are jointly realized according to the drug effects of the traditional Chinese medicines of the raw materials, the traditional Chinese medicine has stronger effects of relieving cough, reducing phlegm, eliminating sore throat and moistening throat and trachea, and the treatment effect of patients with chronic cough is enhanced.
Drawings
In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present application, and for those skilled in the art, other drawings can be obtained according to the drawings without creative efforts.
Fig. 1 is a flowchart of a method for preparing a pill for treating persistent cough according to an embodiment of the present invention.
Detailed Description
In order to make those skilled in the art better understand the technical solutions in the present application, the technical solutions in the embodiments of the present application will be clearly and completely described below with reference to the drawings in the embodiments of the present application, and it is obvious that the described embodiments are only a part of the embodiments of the present application, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
It will be understood that when an element is referred to as being "fixed" or "disposed" on another element, it can be directly on the other element or be indirectly disposed on the other element; when an element is referred to as being "connected to" another element, it can be directly connected to the other element or be indirectly connected to the other element.
It will be understood that the terms "length," "width," "upper," "lower," "front," "rear," "first," "second," "vertical," "horizontal," "top," "bottom," "inner," "outer," and the like, as used herein, refer to an orientation or positional relationship indicated in the drawings that is solely for the purpose of facilitating the description and simplifying the description, and do not indicate or imply that the referenced device or element must have a particular orientation, be constructed and operated in a particular orientation, and thus should not be considered as limiting the present application.
Furthermore, the terms "first", "second" and "first" are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of the present application, "plurality" or "a plurality" means two or more unless specifically limited otherwise.
It should be understood that the structures, ratios, sizes, and the like shown in the drawings are only for illustrative purposes and are not intended to limit the scope of the present disclosure, so that those skilled in the art can understand and read the present disclosure, and the present disclosure is not limited to the conditions and conditions that can be implemented in the present disclosure.
The application provides a pill medicine for treating cough, which comprises the following components in parts by weight: 0.6-1.5 parts of bulbus fritillariae cirrhosae, 0.3-1.8 parts of radix trichosanthis, 0.5-1.6 parts of flos farfarae, 0.8-1.2 parts of agilawood, 0.8-3 parts of myrobalan, 1-2.6 parts of mint leaf, 0.8-1.2 parts of radix asparagi, 0.3-1.8 parts of radix ophiopogonis, 0.6-1.8 parts of aster, 0.2-1.5 parts of radix scrophulariae, 0.4-2 parts of platycodon grandiflorum, 0.8-1.8 parts of meadowrue, 0.2-1.6 parts of five liao flavor, 0.4-1 part of dark plum pulp, 2-8 parts of dried persimmon, 0.8-2.6 parts of pear, 0.5-2.5 parts of radish, 1.5-3.6 parts of maltose, 0.1-0.8 parts of mirabilitum powder and 0.8-2 parts of ginger.
Compared with the prior art, the pill medicine for treating persistent cough provided by the invention comprises the following components in parts by weight: 0.6 to 1.5 parts of bulbus fritillariae cirrhosae, 0.3 to 1.8 parts of radix trichosanthis, 0.5 to 1.6 parts of flos farfarae, 0.8 to 1.2 parts of agilawood, 0.8 to 3 parts of myrobalan, 1 to 2.6 parts of mint leaf, 0.8 to 1.2 parts of radix asparagi, 0.3 to 1.8 parts of radix ophiopogonis, 0.6 to 1.8 parts of aster, 0.2 to 1.5 parts of radix scrophulariae, 0.4 to 2 parts of platycodon grandiflorum, 0.8 to 1.8 parts of meadowrue, 0.2 to 1.6 parts of five liao flavor, 0.4 to 1 part of dark plum pulp, 2 to 8 parts of dried persimmon, 0.8 to 2.6 parts of pear, 0.5 to 2.5 parts of radish, 1.5 to 3.6 parts of maltose, 0.1 to 0.8 parts of mirabilitum powder and 0.8 to 2 parts of ginger, therefore, the traditional Chinese medicine raw materials are adopted, the safety is better, the effects are jointly realized according to the drug effects of the traditional Chinese medicines of the raw materials, the traditional Chinese medicine has stronger effects of relieving cough, reducing phlegm, eliminating sore throat and moistening throat and trachea, and the treatment effect of patients with chronic cough is enhanced.
Specifically, in the embodiment of the invention, the paint comprises the following components in parts by weight: 0.8-1.2 parts of bulbus fritillariae cirrhosae, 0.5-1.4 parts of radix trichosanthis, 0.6-1.2 parts of flos farfarae, 0.8-1.1 parts of agilawood, 1.1-2.8 parts of myrobalan, 1.4-2.3 parts of mint leaf, 0.8-1.1 parts of radix asparagi, 0.6-1.5 parts of radix ophiopogonis, 0.8-1.4 parts of aster, 0.4-1.2 parts of radix scrophulariae, 0.6-1.8 parts of platycodon grandiflorum, 0.8-1.4 parts of meadowrue, 0.3-1.1 parts of Liaowuwei, 0.5-0.9 parts of dark plum pulp, 2-6 parts of dried persimmon, 1-2.2 parts of pear, 0.8-2.5 parts of radish, 1.6-3.2 parts of maltose, 0.1-0.5 parts of glauber salt and 0.8-1.5 parts of ginger.
Specifically, in the embodiment of the invention, the paint comprises the following components in parts by weight: 0.8-1.1 part of bulbus fritillariae cirrhosae, 0.8-1.2 parts of radix trichosanthis, 0.8-1.1 part of flos farfarae, 0.9-1.1 part of agilawood, 1.5-2.4 parts of myrobalan, 1.6-2.2 parts of mint leaf, 0.9-1.1 part of radix asparagi, 0.8-1.2 parts of radix ophiopogonis, 0.9-1.3 parts of aster, 0.8-1.2 parts of radix scrophulariae, 0.8-1.3 parts of platycodon grandiflorum, 0.9-1.2 parts of meadowrue, 0.5-1 part of Liaowuwei, 0.6-0.9 part of dark plum pulp, 3-6 parts of dried persimmon, 1-2.2 parts of pear, 0.8-2.5 parts of radish, 1.8-2.8 parts of maltose, 0.1-0.4 part of mirabilitum and 0.8-1.5 part of ginger.
Specifically, in the embodiment of the invention, the pear is a denucleated snow pear.
It should be added that, in the embodiment of the present invention, the following components by weight are included: 1 part of bulbus fritillariae cirrhosae, 1 part of radix trichosanthis, 1 part of flos farfarae, 1 part of agilawood, 2 parts of myrobalan, 2 parts of mint leaf, 1 part of radix asparagi, 1 part of radix ophiopogonis, 1 part of aster, 1 part of radix scrophulariae, 1 part of platycodon grandiflorum, 1 part of meadowrue, 0.7 part of five liao-flavor, 0.7 part of dark plum pulp, 1-2.2 parts of pear, 0.8-2.5 parts of radish, 2 parts of maltose, 0.3 part of mirabilitum dehydratum and 0.8-1.5 parts of ginger.
More specifically, the pill medicine for treating the cough comprises the following components in parts by weight: 1 two of bulbus fritillariae cirrhosae, 1 two of radices trichosanthis, 1 two of flos farfarae, 1 two of agilawood, 2 two of myrobalan, 2 two of mint leaves, 1 two of radix asparagi, 1 two of radix ophiopogonis, 1 two of aster, 1 two of radix scrophulariae, 1 two of platycodon grandiflorum, 1 two of powder grass, 0.7 two of five liao flavors, 0.7 two of dark plum flesh, 4 two of dried persimmons, 2 two of maltose and 0.3 two of glauber salt.
As shown in fig. 1, the present invention also provides a preparation method of the pill medicine for treating persistent cough, which comprises the following steps:
s1, preparing medicinal powder: drying Bulbus Fritillariae Cirrhosae, Trichosanthis radix, flos Farfarae, lignum Aquilariae Resinatum, fructus Chebulae and folium Menthae, pulverizing, and sieving with 50 mesh sieve to obtain first medicinal powder;
s2, preparing pear juice: adding water, decocting the denucleated snow pears, and removing residues to obtain pear juice;
s3, preparing an ointment: respectively juicing ginger and radish, removing residues to obtain a mixed solution, drying and crushing cochinchnese asparagus root, dwarf lilyturf tuber, aster, radix scrophulariae, platycodon grandiflorum, meadowrue root, five flavors of Chinese Liaoning, dark plum pulp and mirabilitum dehydratum, sieving with a sieve of 100 meshes and 150 meshes to obtain a second medicinal powder, adding the second medicinal powder and maltose into the mixed solution, mixing, and heating to obtain a paste to obtain an ointment;
s4, preparing pills: mixing the ointment with the first medicinal powder, standing for 15-30 minutes, and making into pill.
In addition, in the embodiment of the present invention, in the step S3, the heating temperature after the second powder and the maltose are added to the mixed solution is 80-100 ℃.
In addition, in the embodiment of the present invention, in the step S3, the second powder, the maltose and the mixed solution need to be stirred during the heating process.
Specifically, in the embodiment of the present invention, the weight component of the pear juice in the step S2 is 8 to 15 parts.
Specifically, in the embodiment of the present invention, the weight component of the mixed liquid in the step S4 is 8 to 16 parts.
Specifically, in the embodiment of the present invention, the weight component of the ginger juice in the step S4 is 0.1 part.
It should be added that, in the embodiment of the present invention, the weight of the pills in step S4 is 3-5 g/pill.
To better illustrate the therapeutic effect of the pill medication for treating more than constant cough referred to in the examples of the present invention, the following evaluation experiments were performed:
the pill medicine for treating the persistent cough and the penicillin intravenous drip on the market are taken as examples respectively, and the cough-relieving curative effect is judged for 12 weeks.
150 patients with cough were selected and randomized into three groups of 50 patients, all meeting the following cough diagnostic criteria:
1) clear respiratory tract infection symptoms, such as pharyngalgia, sneeze, cough, fever, rhinorrhea, etc.;
2) the X-ray chest radiography examination is abnormal, and the sputum cytology examination is normal;
3) cough caused by external gastroesophageal reflux, cough variant asthma, tuberculosis, chronic obstructive pulmonary disease, lung cancer and the like are not included.
Specific information for each experimental group is as follows:
1) experiment group one: 28 men and 22 women, wherein the ages are 20-63 years, the mean age (39.75 +/-6.23) years, the course of disease is 3-8 years, and the mean course of disease (4.58 +/-1.36) years;
2) experiment group two: 29 men and 21 women, age 19-62 years, mean age (39.15 + -6.09) years, course 3-8 years, mean course (4.53 + -1.34) years;
3) experiment group three: 30 men and 20 women, age 21-62 years, mean age (39.69 + -6.32 years), course 3-8 years, mean course (4.57 + -1.35 years).
The general data comparison differences of sex, age, course of disease and the like of the three groups of patients have no statistical significance and are comparable, the three groups of patients are respectively treated by the pill medicine for treating more than one cough, the penicillin intravenous drip treatment and the penicillin intravenous drip, and the pill medicine for treating more than one cough related to the embodiment of the invention is respectively used for the three groups of patients for jointly treating the cough, and the cough treatment effects of the three groups of patients are compared respectively in the 2 nd week and the 12 th group, and the method comprises the following steps: the frequency and influence of daytime coughs before and after treatment, the frequency and influence of nighttime coughs, the recurrence rate and the grade of life quality.
The pill medicine for treating the persistent cough is adopted for treating the patient in the first experimental group 3 pills at a time for 3 times in 1 day, the patient in the second experimental group is treated by intravenous drip of penicillin for 2 times in a day, the pill medicine for treating the persistent cough is dripped into the patient in the third experimental group by intravenous drip of penicillin for co-treatment, the cough effect comparison table and the treatment shown in the table 1 are obtained after the three groups of patients are treated for 2 weeks at the same time, and the patient is noticed to avoid eating spicy and greasy food as much as possible during the treatment period so as to avoid influencing the curative effect of the treatment.
TABLE 1 comparison of the effects of the three cough treatments
| Group of | n | Clinical cure | Show effect | Is effective | Invalidation | Increasing the rate of the disease | Total effective rate |
| Experiment set 1 | 50 | 22 | 12 | 13 | 3 | 68％ | 94％ |
| Experiment group two | 50 | 18 | 6 | 14 | 12 | 48％ | 76％ |
| Experiment group III | 50 | 24 | 14 | 10 | 2 | 76％ | 96％ |
TABLE 2 comparison of relapse rates for three groups of 16 weeks of treatment
| Group of | n | The number of relapsing people | Recurrence rate |
| Experiment set 1 | 50 | 5 | 10％ |
| Experiment group two | 50 | 12 | 24％ |
| Experiment group III | 50 | 4 | 8％ |
It should be noted that, in the present evaluation experiment, the total disease efficacy was determined by calculating the efficacy index according to the nindipine method, where the efficacy index (N) ═ integration before treatment-integration after treatment)/integration before treatment × 100%.
Wherein, the clinical cure is as follows: the curative effect index (N) is more than or equal to 95 percent, and clinical symptoms and physical signs disappear or basically disappear;
remarkably: the curative effect index (N) is more than or equal to 70 percent, and the clinical symptoms and physical signs are all improved;
the method has the following advantages: the curative effect index (N) is more than or equal to 30 percent, and the clinical symptoms and physical signs are improved;
and (4) invalidation: the curative effect index (N) is less than 30%, and the clinical symptoms and physical signs are not obviously improved or aggravated.
The day cough reference score table and the night cough reference score table in table 3 below were referenced to obtain day and night cough score tables for the three cough treatment groups in table 5 before and after 2 weeks.
TABLE 3 reference integral table for daytime coughing
| Frequency and effects of cough | Daytime cough integral (minute) |
| Without cough | 0 |
| 1-2 times of cough | 1 |
| Short-term cough with cough frequency more than 2 times | 2 |
| Frequent coughing but no effect on daily activity | 3 |
| Frequent coughing and impact on daily activity | 4 |
| Violent cough and incapability of doing exercise | 5 |
TABLE 4 reference integral table for cough at night
TABLE 5 cough score table for cough treatment before and after 2 weeks in daytime and at night
As can be seen from the results in tables 1 and 5, the daytime cough score and the nighttime cough score of the two groups of patients treated with the pill for treating persistent cough provided by the present application are lower than those of the two groups of patients not treated with the pill for treating persistent cough provided by the present application, and the quality of life score of the former group is higher than that of the latter group of patients, and meanwhile, after three months of treatment, the recurrence rate of the two groups of patients treated with the pill for treating persistent cough provided by the present application is lower than that of the two groups of patients not treated with the pill for treating persistent cough provided by the present application.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (8)
1. A pill medicine for treating cough is characterized by comprising the following components in parts by weight: 0.6-1.5 parts of bulbus fritillariae cirrhosae, 0.3-1.8 parts of radix trichosanthis, 0.5-1.6 parts of flos farfarae, 0.8-1.2 parts of agilawood, 0.8-3 parts of myrobalan, 1-2.6 parts of mint leaf, 0.8-1.2 parts of radix asparagi, 0.3-1.8 parts of radix ophiopogonis, 0.6-1.8 parts of aster, 0.2-1.5 parts of radix scrophulariae, 0.4-2 parts of platycodon grandiflorum, 0.8-1.8 parts of meadowrue, 0.2-1.6 parts of five liao flavor, 0.4-1 part of dark plum pulp, 2-8 parts of dried persimmon, 0.8-2.6 parts of pear, 0.5-2.5 parts of radish, 1.5-3.6 parts of maltose, 0.1-0.8 parts of mirabilitum powder and 0.8-2 parts of ginger.
2. The pill for treating more than cough according to claim 1, comprising the following components by weight: 0.8-1.2 parts of bulbus fritillariae cirrhosae, 0.5-1.4 parts of radix trichosanthis, 0.6-1.2 parts of flos farfarae, 0.8-1.1 parts of agilawood, 1.1-2.8 parts of myrobalan, 1.4-2.3 parts of mint leaf, 0.8-1.1 parts of radix asparagi, 0.6-1.5 parts of radix ophiopogonis, 0.8-1.4 parts of aster, 0.4-1.2 parts of radix scrophulariae, 0.6-1.8 parts of platycodon grandiflorum, 0.8-1.4 parts of meadowrue, 0.3-1.1 parts of Liaowuwei, 0.5-0.9 parts of dark plum pulp, 2-6 parts of dried persimmon, 1-2.2 parts of pear, 0.8-2.5 parts of radish, 1.6-3.2 parts of maltose, 0.1-0.5 parts of glauber salt and 0.8-1.5 parts of ginger.
3. The pill for treating more than cough according to claim 2, characterized by comprising the following components by weight: 0.8-1.1 part of bulbus fritillariae cirrhosae, 0.8-1.2 parts of radix trichosanthis, 0.8-1.1 part of flos farfarae, 0.9-1.1 part of agilawood, 1.5-2.4 parts of myrobalan, 1.6-2.2 parts of mint leaf, 0.9-1.1 part of radix asparagi, 0.8-1.2 parts of radix ophiopogonis, 0.9-1.3 parts of aster, 0.8-1.2 parts of radix scrophulariae, 0.8-1.3 parts of platycodon grandiflorum, 0.9-1.2 parts of meadowrue, 0.5-1 part of Liaowuwei, 0.6-0.9 part of dark plum pulp, 3-6 parts of dried persimmon, 1-2.2 parts of pear, 0.8-2.5 parts of radish, 1.8-2.8 parts of maltose, 0.1-0.4 part of mirabilitum and 0.8-1.5 part of ginger.
4. A pill for the treatment of more than one cough according to claim 3, wherein said pear is an enucleated snow pear.
5. A method for preparing a bolus medicament for treating more than one cough as claimed in claim 4, comprising the steps of:
s1, preparing medicinal powder: drying Bulbus Fritillariae Cirrhosae, Trichosanthis radix, flos Farfarae, lignum Aquilariae Resinatum, fructus Chebulae and folium Menthae, pulverizing, and sieving with 50 mesh sieve to obtain first medicinal powder;
s2, preparing pear juice: adding water, decocting the denucleated snow pears, and removing residues to obtain pear juice;
s3, preparing an ointment: respectively juicing ginger and radish, removing residues to obtain a mixed solution, drying and crushing cochinchnese asparagus root, dwarf lilyturf tuber, aster, radix scrophulariae, platycodon grandiflorum, meadowrue root, five flavors of Chinese Liaoning, dark plum pulp and mirabilitum dehydratum, sieving with a sieve of 100 meshes and 150 meshes to obtain a second medicinal powder, adding the second medicinal powder and maltose into the mixed solution, mixing, and heating to obtain a paste to obtain an ointment;
s4, preparing pills: mixing the ointment with the first medicinal powder, standing for 15-30 minutes, and making into pill.
6. The method for preparing a pill for treating more than cough according to claim 5, wherein the weight component of the pear juice in the step S2 is 8-15 parts.
7. The method for preparing a pill for treating cough according to claim 6, wherein the weight components of the mixed solution in the step S4 are 8-16 parts.
8. The method for preparing a pill for the treatment of more than one cough according to claim 7, wherein the weight component of the ginger juice in the step S4 is 0.1 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111220593.9A CN113952439A (en) | 2021-10-20 | 2021-10-20 | Pill medicine for treating persistent cough and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111220593.9A CN113952439A (en) | 2021-10-20 | 2021-10-20 | Pill medicine for treating persistent cough and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113952439A true CN113952439A (en) | 2022-01-21 |
Family
ID=79465653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111220593.9A Pending CN113952439A (en) | 2021-10-20 | 2021-10-20 | Pill medicine for treating persistent cough and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113952439A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102379403A (en) * | 2011-10-18 | 2012-03-21 | 安徽省砀山倍佳福食品有限公司 | Health-care pear syrup and preparation method thereof |
| CN111388642A (en) * | 2020-04-17 | 2020-07-10 | 吕守忠 | Traditional Chinese medicine composition for treating cough |
-
2021
- 2021-10-20 CN CN202111220593.9A patent/CN113952439A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102379403A (en) * | 2011-10-18 | 2012-03-21 | 安徽省砀山倍佳福食品有限公司 | Health-care pear syrup and preparation method thereof |
| CN111388642A (en) * | 2020-04-17 | 2020-07-10 | 吕守忠 | Traditional Chinese medicine composition for treating cough |
Non-Patent Citations (3)
| Title |
|---|
| 李存英: "中医辨证论治小儿咽源性咳嗽60例", 《中医研究》 * |
| 邓维海 等: "护阴止嗽丹治疗慢性干咳临床观察", 《中医学报》 * |
| 钱玉萍: "止嗽散加味治疗喉源性咳嗽60例", 《中国民间疗法》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101095736A (en) | Chinese traditional medicine composition for treating acute and chronic pharyngitis, tonsillitis and method of making the same | |
| CN106138360A (en) | A kind of Chinese medicine composition and preparation method thereof, application | |
| CN104042947A (en) | Preparation with effect of clearing heat from throat and preparation method thereof | |
| CN110215492A (en) | It is a kind of prevent and treat haze irritable cough Chinese medicine composition and its preparation and application | |
| CN101618146A (en) | Complex traditional Chinese medicine preparation for treating upper respiratory tract infection and preparation method thereof | |
| CN113952439A (en) | Pill medicine for treating persistent cough and preparation method thereof | |
| CN103041151A (en) | Traditional Chinese medicine composition for curing trachitis and preparation method thereof | |
| CN101780211B (en) | Traditional Chinese medicine for treating infantile chronic cough and asthma | |
| CN101474373B (en) | Chinese medicine for treating acute pharyngitis | |
| CN109106774B (en) | Traditional Chinese medicine composition for treating adenoidal hypertrophy and complications thereof, and preparation method and application thereof | |
| CN102380027A (en) | Traditional Chinese medicine composition for treating bronchitis | |
| CN101406685A (en) | Medicament for treating bronchial asthma and preparation method thereof | |
| CN104510937A (en) | Traditional Chinese medicinal formula for treating infantile asthma and preparation method for paste of traditional Chinese medicinal formula | |
| CN111481585A (en) | Pharmaceutical composition for treating chronic pharyngitis and preparation method and application thereof | |
| CN105288134B (en) | Preparation method of pear paste for moistening lung | |
| CN107496745A (en) | A kind of Chinese medicine composition for treating heat asthma | |
| CN116712515B (en) | Traditional Chinese medicine composition for treating fever as well as preparation method and application thereof | |
| CN102727614B (en) | Chinese-western medicine preparation for treating chronic obstructive pulmonary disease | |
| CN113440575B (en) | Traditional Chinese medicine composition for treating cough, yin deficiency and lung heat syndrome after children infection and preparation method | |
| CN108030887A (en) | A kind of Chinese materia medica syrup for being used to treat cough variant asthma in childhood: prednison comparing | |
| CN108308470B (en) | Phlegm-eliminating cough-relieving beverage and preparation method and application thereof | |
| CN101167881B (en) | Lung-clearing composition containing tomato plant stem extraction and preparation method thereof | |
| CN114425064A (en) | Traditional Chinese medicine composition for treating cough and preparation method thereof | |
| CN112168870A (en) | Traditional Chinese medicine cough and asthma paste and preparation method thereof | |
| CN106138594A (en) | A kind of Chinese medicine composition preventing and treating Hormone factor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |